Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical and Experimental Nephrology

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10157-016-1266-8PMID 27108294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate mofetil for sustained remission in nephrotic syndrome

  2018cited by this paper
• Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience

  2016cited by this paper
• Non‐Corticosteroid Immunosuppressive Medications for Steroid‐Sensitive Nephrotic Syndrome in Children

  2015cited by this paper
• Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.

  2014cited by this paper
• Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

  2014cited by this paper
• Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO

  2013cited by this paper
• Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

  2013cited by this paper
• Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.

  2013cited by this paper
• Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial

  2012cited by this paper
• Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome

  2012cited by this paper
• Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

  2009cited by this paper
• New equations to estimate GFR in children with CKD.

  2009cited by this paper
• Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial.

  2008cited by this paper
• Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

  2008cited by this paper
• Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome

  2006cited by this paper
• Long-term results of two unconventional agents in steroid-dependent nephrotic children

  2005cited by this paper
• Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

  2004cited by this paper
• Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.

  1994cited by this paper
• Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

  1993cited by this paper
• Levamisole for corticosteroid-dependent nephrotic syndrome in childhood

  1993cited by this paper
• Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology.

  1991cited by this paper
• Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

  1973cited by this paper
• Nephrotic Syndrome

  1962cited by this paper

• Clinical applicability of 2023 International Pediatric Nephrology Association recommended limited therapeutic drug monitoring formulae to assess mycophenolic acid exposure

  2025cites this paper
• Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

  2025cites this paper
• Steroid-sparing therapy of frequently recurrent nephrotic syndrome with levamizole

  2025cites this paper
• Tacrolimus or Mycophenolate Mofetil for Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome

  2025cites this paper
• A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapy

  2025cites this paper
• Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis

  2024cites this paper
• Childhood nephrotic syndrome.

  2023cites this paper
• Tacrolimus Compared with Other Immunosuppressants in Children with Refractory Nephrotic Syndrome

  2023cites this paper
• Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response

  2023cites this paper
• Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis

  2023cites this paper
• Comparative efficacy of mycophenolic acid and cyclosporine A in treatment of children with steroid-dependent nephrotic syndrome

  2022cites this paper
• IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

  2022influential citation
• [Efficacy and safety of mycophenolate mofetil versus cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria in children: a prospective randomized controlled trial].

  2021cites this paper
• Levamisole and ANCA positivity in childhood nephrotic syndrome

  2021cites this paper
• Steroid Sensitive Nephrotic Syndrome: Revised Guidelines

  2021cites this paper
• Steroid-Sensitive Nephrotic Syndrome

  2021cites this paper
• Сравнительное исследование эффективности цитостатической терапии первого выбора ингибиторами кальцинейрина и ингибиторами синтеза нуклеотидов гормоночувствительного, гормонозависимого и со стероидной токсичностью нефротического синдрома у детей

  2020cites this paper
• Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects

  2019influential citation
• Mycophenolate mofetil for maintenance of remission in children with steroid- and calcineurin inhibitor- dependent nephrotic syndrome: A prospective, randomized multicenter trial

  2019cites this paper
• The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study

  2019cites this paper
• Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome.

  2019cites this paper
• Mycophenolate mofetil for sustained remission in nephrotic syndrome

  2018cites this paper
• Mycophenolate mofetil in paediatric autoimmune or immune‐mediated diseases of the central nervous system: clinical experience and recommendations

  2018cites this paper
• [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].

  2017cites this paper
• Syndrome néphrotique idiopathique corticodépendant de l’enfant : facteurs prédictifs de recours à un traitement immunosuppresseur

  2017cites this paper
• Traitement et évolution du syndrome néphrotique idiopathique cortico-résistant de l’enfant : étude d’une cohorte monocentrique de 68 patients traités par anticalcineurines

  2016cites this paper
• Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience

  2016influential citation
• A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias

  2014cites this paper